253 related articles for article (PubMed ID: 31639019)
1. The Jun N-terminal kinases signaling pathway plays a "seesaw" role in ovarian carcinoma: a molecular aspect.
Dou Y; Jiang X; Xie H; He J; Xiao S
J Ovarian Res; 2019 Oct; 12(1):99. PubMed ID: 31639019
[TBL] [Abstract][Full Text] [Related]
2. JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.
Zhao Z; Wang J; Tang J; Liu X; Zhong Q; Wang F; Hu W; Yuan Z; Nie C; Wei Y
Biochem J; 2012 Jun; 444(2):291-301. PubMed ID: 22394200
[TBL] [Abstract][Full Text] [Related]
3. Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.
Zheng GF; Cai Z; Meng XK; Zhang Y; Zhu W; Pang XY; Dou L
Int J Clin Exp Pathol; 2015; 8(6):6505-11. PubMed ID: 26261528
[TBL] [Abstract][Full Text] [Related]
4. Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines.
Paudel I; Hernandez SM; Portalatin GM; Chambers TP; Chambers JW
Biochem J; 2018 Nov; 475(21):3471-3492. PubMed ID: 30322886
[TBL] [Abstract][Full Text] [Related]
5. PTP1B promotes the malignancy of ovarian cancer cells in a JNK-dependent mechanism.
Wang W; Cao Y; Zhou X; Wei B; Zhang Y; Liu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):903-909. PubMed ID: 29928877
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane Inhibits Proliferation and Invasion of Human Ovarian Cancer Cells by Regulating JNK and p38 MAPK Signaling Pathway.
Kang K; Wang Y
Drug Des Devel Ther; 2019; 13():4451-4460. PubMed ID: 32021086
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway.
Chen Q; Chen P; Pang X; Hu Y; Zhang Y
Int J Gynecol Cancer; 2015 Jul; 25(6):953-60. PubMed ID: 26098087
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways.
Wang TH; Chan YH; Chen CW; Kung WH; Lee YS; Wang ST; Chang TC; Wang HS
Oncogene; 2006 Aug; 25(35):4857-66. PubMed ID: 16547493
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium selenite on c-Jun N-terminal kinase signalling pathway induced by oxidative stress in human chondrocytes and c-Jun N-terminal kinase expression in patients with Kashin-Beck disease, an endemic osteoarthritis.
Dai X; Li Y; Zhang R; Kou Y; Mo X; Cao J; Xiong Y
Br J Nutr; 2016 May; 115(9):1547-55. PubMed ID: 26948765
[TBL] [Abstract][Full Text] [Related]
10. Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.
Seino M; Okada M; Shibuya K; Seino S; Suzuki S; Ohta T; Kurachi H; Kitanaka C
Anticancer Res; 2014 Sep; 34(9):4723-31. PubMed ID: 25202050
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
13. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
14. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
Li DD; Wang LL; Deng R; Tang J; Shen Y; Guo JF; Wang Y; Xia LP; Feng GK; Liu QQ; Huang WL; Zeng YX; Zhu XF
Oncogene; 2009 Feb; 28(6):886-98. PubMed ID: 19060920
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
17. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
18. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
19. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas.
Papachristou DJ; Batistatou A; Sykiotis GP; Varakis I; Papavassiliou AG
Bone; 2003 Apr; 32(4):364-71. PubMed ID: 12689679
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]